MRUS logo

Merus N.V. (MRUS)

Profile

Full Name

Merus N.V.

Ticker

NASDAQ: MRUS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Netherlands

IPO

May 19, 2016

Indexes

Not included

Website

https://www.merus.nl

Employees

260

Key Details

Price

$94.95(0.13%)

Market Cap

$7.20B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$36.13M(-17.78% YoY)

Annual EPS

-$3.35(-11.67% YoY)

PE Ratio

-

Next earnings date

Oct 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $94.95
    MRUS price is $94.95

    30-Day Relative Volume

    0.72
    MRUS 30-day relative volume is 0.72

    Price Performance

    Price Most Recent Change

    +0.13%
    MRUS price was up +0.13% on Oct 15, 2025

    Price YTD Change

    +125.8%
    MRUS price is up +125.8% since January 1st

    Price 1-Year Change

    +84.91%
    MRUS price is up +84.91% year-on-year

    Price 3-Year Change

    +331.59%
    MRUS price is up +331.59% over the past 3 years

    Price Range

    Price All-Time High

    $95.02
    MRUS price is currently -0.07% below its historical high of $95.02

    Price 3-Year Low

    $12.03
    MRUS price is currently +689.28% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $7.20B
    MRUS market cap is $7.20 billion

    Market Cap 3-Year Change

    +606.39%
    MRUS market cap is up +606.39% over the past 3 years

    Market Cap All-Time High

    $7.20B
    MRUS market cap is currently at an all-time high

    Market Cap Sector Percentile

    89.63%
    MRUS market cap is higher than 89.63% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +10.75%
    MRUS shares outstanding is up +10.75% year-on-year

    Shares Outstanding 3-Year Change

    +63.67%
    MRUS shares outstanding is up +63.67% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.98
    MRUS beta is 0.98

    200-day SMA

    $54.33
    MRUS price is currently +74.77% above its 200-day simple moving average

    50-day SMA

    $74.03
    MRUS price is currently +28.26% above its 50-day simple moving average

    14-Day RSI

    85.84
    MRUS 14-day relative strength index is 85.84

    Volume

    0.72
    MRUS 30-day relative volume is 0.72

    ATR

    $1.80
    MRUS average true range is $1.80

    10-day Historical Volatility

    3.07%
    MRUS 10-day historical volatility is 3.07%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $36.13M
    MRUS annual revenue is $36.13 million

    Revenue Analysts Estimate

    $52.60M
    MRUS annual revenue is currently -31.30% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -17.78%
    MRUS annual revenue is down -17.78% year-on-year

    Revenue Sector Percentile

    58.7%
    MRUS annual revenue is higher than 58.7% of companies in Healthcare sector

    EPS

    EPS

    -$3.35
    MRUS annual earnings per share is -$3.35

    EPS Analysts Estimate

    -$5.60
    MRUS annual earnings per share is currently +40.17% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -11.67%
    MRUS annual earnings per share is down -11.67% year-on-year

    EPS Sector Percentile

    27.51%
    MRUS annual earnings per share is higher than 27.51% of companies in Healthcare sector

    Profit

    Gross Profit

    $0.00
    MRUS annual gross profit is $0.00

    Gross Margin

    0.00%
    MRUS annual gross profit margin is 0.00%

    Operating Profit

    -$272.07M
    MRUS annual operating income is -$272.07 million

    Operating Margin

    -752.96%
    MRUS annual operating profit margin is -752.96%

    Net Income

    -$215.33M
    MRUS annual net profit is -$215.33 million

    Net Margin

    -595.93%
    MRUS annual net profit margin is -595.93%

    Expenses

    Total Expenses

    $251.46M
    MRUS annual total expenses is $251.46 million

    Operating Expenses

    $272.07M
    MRUS annual total operating expenses is $272.07 million

    Cost Of Goods Sold

    -
    MRUS annual cost of goods sold value is unknown

    Selling, General & Administrative Expenses

    $82.83M
    MRUS annual SG&A is $82.83 million

    Depreciation & Amortization

    $2.47M
    MRUS annual D&A is $2.47 million

    Interest Expense

    $0.00
    MRUS annual interest expense is $0.00

    Income Tax

    $8.15M
    MRUS annual income tax is $8.15 million

    EBIT & EBITDA

    EBIT

    -$272.07M
    MRUS annual earnings before interest & taxes is -$272.07 million

    EBITDA

    -$269.60M
    MRUS annual EBITDA is -$269.60 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $785.13M
    MRUS annual total assets is $785.13 million

    Non Current Assets

    $213.62M
    MRUS annual long term assets is $213.62 million

    Current Assets

    $569.07M
    MRUS annual total current assets is $569.07 million

    Cash and Cash Equivalents

    $293.29M
    MRUS annual cash & cash equivalents is $293.29 million

    Accounts Receivable

    $1.26M
    MRUS annual accounts receivable is $1.26 million

    Inventory

    $0.00
    MRUS annual inventory is $0.00

    Liabilities

    Total Liabilities

    $137.20M
    MRUS annual total liabilities is $137.20 million

    Long Term Liabilities

    $47.69M
    MRUS annual total long term liabilities is $47.69 million

    Current Liabilities

    $87.08M
    MRUS annual current liabilities is $87.08 million

    Accounts Payable

    $4.16M
    MRUS annual accounts payable is $4.16 million

    Debt

    Total Debt

    $9.91M
    MRUS annual total debt is $9.91 million

    Total Debt 1-Year Change

    -18.5%
    MRUS annual total debt is down -18.5% year-on-year

    Long Term Debt

    $8.21M
    MRUS annual long term debt is $8.21 million

    Short Term Debt

    $1.70M
    MRUS annual short term debt is $1.70 million

    Equity & Capital

    Shareholders Equity

    $647.93M
    MRUS annual stockholders equity is $647.93 million

    Book Value

    $647.93M
    MRUS annual book value is $647.93 million

    Retained Earnings

    -$968.39M
    MRUS annual retained earnings is -$968.39 million

    Working Capital

    $482.00M
    MRUS annual working capital is $482.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$185.84M
    MRUS annual cash from operations is -$185.84 million

    Cash From Operations 1-Year Change

    -30.68%
    MRUS annual cash from operations is down -30.68% year-on-year

    Cash From Investing

    -$220.22M
    MRUS annual cash from investing is -$220.22 million

    Cash From Investing 1-Year Change

    -715.03%
    MRUS annual cash from investing is down -715.03% year-on-year

    Cash From Financing

    $494.01M
    MRUS annual cash from financing is $494.01 million

    Cash From Financing 1-Year Change

    +114.71%
    MRUS annual cash from financing is up +114.71% year-on-year

    CAPEX

    CAPEX

    $1.83M
    MRUS annual capital expenditures is $1.83 million

    CAPEX 1-Year Change

    -54.04%
    MRUS annual capital expenditures is down -54.04% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$187.66M
    MRUS annual free cash flow is -$187.66 million

    Free Cash Flow 1-Year Change

    -28.37%
    MRUS annual free cash flow is down -28.37% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    0.00%
    MRUS annual gross profit margin is 0.00%

    Operating Margin

    -752.96%
    MRUS annual operating profit margin is -752.96%

    Net Margin

    -595.93%
    MRUS annual net profit margin is -595.93%

    ROA & ROE

    ROA

    -34.63%
    MRUS annual return on assets is -34.63%

    ROE

    -42.88%
    MRUS annual return on equity is -42.88%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    MRUS price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    MRUS price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    8.55
    MRUS price to book ratio is 8.55

    PB Ratio Sector Percentile

    85.55%
    MRUS price to book ratio is higher than 85.55% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    127.97
    MRUS price to sales ratio is 127.97

    PS Ratio Sector Percentile

    90.56%
    MRUS price to sales ratio is higher than 90.56% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $6.50B
    MRUS enterprise value is $6.50 billion

    Enterprise Value Sector Percentile

    88.85%
    MRUS enterprise value is higher than 88.85% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -18.86
    MRUS EV/EBITDA is -18.86

    EV/EBITDA Sector Percentile

    8.75%
    MRUS EV/EBITDA is higher than 8.75% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    6.54
    MRUS annual current ratio is 6.54

    Quick Ratio

    6.54
    MRUS annual quick ratio is 6.54

    Leverage

    Debt To Equity

    0.02
    MRUS annual debt to equity ratio is 0.02

    Interest Coverage Ratio

    -
    MRUS annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    4
    MRUS piotroski f-score is 4

    Altman Z-Score

    29.38
    MRUS altman z-score is 29.38

    Analyst ratings

    Recent major analysts updates

    Oct 6, 25 Leerink Partners
    Market Perform
    Sep 30, 25 Wells Fargo
    Equal-Weight
    Sep 30, 25 UBS
    Neutral
    Sep 30, 25 LifeSci Capital
    Market Perform
    Sep 30, 25 HC Wainwright & Co.
    Neutral
    Sep 30, 25 Guggenheim
    Neutral
    Sep 30, 25 Canaccord Genuity
    Hold
    Sep 30, 25 Barclays
    Equal-Weight
    Sep 29, 25 Wells Fargo
    Equal-Weight
    Sep 29, 25 Truist Securities
    Hold

    Institutional Ownership

    Screeners with MRUS included

    Growing Shares Outstanding
    Mid cap stocks
    Best performing stocks last month
    Stocks recommended to hold
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Merus N.V.?
    • Does Merus N.V. pay dividends?
    • What sector is Merus N.V. in?
    • What industry is Merus N.V. in?
    • What country is Merus N.V. based in?
    • When did Merus N.V. go public?
    • Is Merus N.V. in the S&P 500?
    • Is Merus N.V. in the NASDAQ 100?
    • Is Merus N.V. in the Dow Jones?
    • When was Merus N.V.'s last earnings report?
    • When does Merus N.V. report earnings?

    What is the ticker symbol for Merus N.V.?

    The ticker symbol for Merus N.V. is NASDAQ:MRUS

    Does Merus N.V. pay dividends?

    No, Merus N.V. does not pay dividends

    What sector is Merus N.V. in?

    Merus N.V. is in the Healthcare sector

    What industry is Merus N.V. in?

    Merus N.V. is in the Biotechnology industry

    What country is Merus N.V. based in?

    Merus N.V. is headquartered in Netherlands

    When did Merus N.V. go public?

    Merus N.V.'s initial public offering (IPO) was on May 19, 2016

    Is Merus N.V. in the S&P 500?

    No, Merus N.V. is not included in the S&P 500 index

    Is Merus N.V. in the NASDAQ 100?

    No, Merus N.V. is not included in the NASDAQ 100 index

    Is Merus N.V. in the Dow Jones?

    No, Merus N.V. is not included in the Dow Jones index

    When was Merus N.V.'s last earnings report?

    Merus N.V.'s most recent earnings report was on August 5, 2025

    When does Merus N.V. report earnings?

    The next expected earnings date for Merus N.V. is October 30, 2025
    On this page